RD162

• CAT Number: I011443
• CAS Number: 915087-27-3
• Molecular Formula: C22H16F4N4O2S
• Molecular Weight: 476.45
• Purity: ≥95%
• Synonyms: 4-[7-[4-cyano-3-(trifluoromethyl)phenyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl-benzamide
• Target: Androgen Receptor
• Solubility: Soluble in DMSO
• Storage: Store at 4°C
• IUPAC Name: 4-[7-[4-cyano-3-(trifluoromethyl)phenyl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide
• InChI: InChI=1S/C22H16F4N4O2S/c1-28-18(31)15-6-5-14(10-17(15)23)30-20(33)29(19(32)21(30)7-2-8-21)13-4-3-12(11-27)16(9-13)22(24,25)26/h3-6,9-10H,2,7-8H2,1H3,(H,28,31)
• InChIKey: JPQFGMYHKSKKGW-UHFFFAOYSA-N
• SMILES: CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(C=C4)C#N)C(F)(F)F)F

RD162（Cat No.:I011443） is a potent and selective androgen receptor antagonist, widely used in advanced pharmaceutical research. It plays a crucial role in the study of prostate cancer treatment by inhibiting androgen receptor signaling, which is essential for the growth and survival of prostate cancer cells. RD162’s high specificity and efficacy make it a valuable tool for drug development and cancer research. Its consistent performance and reliability ensure precise experimental results, providing a robust and cost-effective solution for high-precision scientific investigations and therapeutic advancements in oncology.